Page last updated: 2024-10-15

chloroacetaldehyde and Renal Insufficiency

chloroacetaldehyde has been researched along with Renal Insufficiency in 1 studies

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L1
Xiong, X1
Hou, X1
Wei, H1
Zhai, J1
Xia, T1
Gong, X1
Gao, S1
Feng, G1
Tao, X1
Zhang, F1
Chen, W1

Other Studies

1 other study available for chloroacetaldehyde and Renal Insufficiency

ArticleYear
Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in rats.
    Basic & clinical pharmacology & toxicology, 2019, Volume: 125, Issue:2

    Topics: Acetaldehyde; Animals; Brain; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship,

2019